ASP Isotopes Inc.
Case Overview
45 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 02/03/2025 |
Status: | Status: Investigating |
Company Name: | Company Name: ASP Isotopes Inc. |
Court: | Court: Southern District of New York |
Case Number: | Case Number: 1:24cv09253 |
Class Period: | Class Period: 10/30/2024 - 11/26/2024 |
Ticker: | Ticker: ASPI |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired ASP Isotopes Inc. (“ASP” or the “Company”) (NASDAQ:ASPI) securities during the period of October 30, 2024, to November 26, 2024, inclusive (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
On November 26, 2024, Fuzzy Panda Research published a report which alleged that ASP is “using old, disregarded laser enrichment technology to masquerade as a new, cutting-edge Uranium enrichment.” The reported quoted a former employee of Klydon, the company ASP purchased its “proprietary” technology from, as stating scientists “did not think it would work on Uranium.” The report also interviewed a series of experts, who stated that the Company’s reported cost estimates and timelines for building its High-Array Low-Enriched Uranium (“HALEU”) facilities were misleading to the point of being “delusional.” The report further alleged that ASP had significantly overstated the significance of its agreement with TerraPower, which was only a ‘non-binding” memorandum of understanding entered to “put pressure on TerraPower’s real suppliers.” Finally, the report alleged that ASP’s subsidiary, Quantum Leap Energy, which operates its nuclear fuels segment and to which the Company assigned the TerraPower memoranda of understanding, was completely absent from its registered South African address. The report revealed that there were “zero signs” of their presence and “security guards and neighboring business about them all told us they had never heard of the companies.” On this news, the price of ASP shares declined by $1.80 per share, or approximately 23.5%, from $7.65 per share on November 25, 2024, to close at $5.85 per share on November 26, 2024.
The complaint alleges that defendants, throughout the Class Period, failed to disclose to investors that: (1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company's nuclear fuels operating segment results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On November 26, 2024, Fuzzy Panda Research published a report which alleged that ASP is “using old, disregarded laser enrichment technology to masquerade as a new, cutting-edge Uranium enrichment.” The reported quoted a former employee of Klydon, the company ASP purchased its “proprietary” technology from, as stating scientists “did not think it would work on Uranium.” The report also interviewed a series of experts, who stated that the Company’s reported cost estimates and timelines for building its High-Array Low-Enriched Uranium (“HALEU”) facilities were misleading to the point of being “delusional.” The report further alleged that ASP had significantly overstated the significance of its agreement with TerraPower, which was only a ‘non-binding” memorandum of understanding entered to “put pressure on TerraPower’s real suppliers.” Finally, the report alleged that ASP’s subsidiary, Quantum Leap Energy, which operates its nuclear fuels segment and to which the Company assigned the TerraPower memoranda of understanding, was completely absent from its registered South African address. The report revealed that there were “zero signs” of their presence and “security guards and neighboring business about them all told us they had never heard of the companies.” On this news, the price of ASP shares declined by $1.80 per share, or approximately 23.5%, from $7.65 per share on November 25, 2024, to close at $5.85 per share on November 26, 2024.
The complaint alleges that defendants, throughout the Class Period, failed to disclose to investors that: (1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company's nuclear fuels operating segment results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.